OSAKA, Japan — (BUSINESS WIRE) — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced the completion of its previously-announced sale of a portfolio of sele…
Takeda Completes Sale of Select OTC and Non-Core Assets to STADA
OSAKA, Japan — (BUSINESS WIRE) — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced the completion of its previously-announced sale of a portfolio of sele…